FilingSEC EDGAR144Acrivon Therapeutics, Inc. filed Form 144Aug 25, 2026, 20:40 ET · SEC acceptedSummaryFiling infoView sourceFiling contentPlease check the source for details.Related companiesAcrivon Therapeutics, Inc.ACRVView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…